Status:
RECRUITING
A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"
Lead Sponsor:
Yan Li
Conditions:
Hypertension
Blood Pressure
Eligibility:
All Genders
18-80 years
Brief Summary
24 hour ambulatory blood pressure (ABP) monitoring should be the first choice for diagnosis and treatment of hypertension according to European Societyof Hypertension (ESH) and the European Society of...
Detailed Description
Hypertension is the most common cardiovascular disease, and it is a fatal disease causing stroke, myocardial infarction and heart failure. Effective blood pressure management can greatly reduce the in...
Eligibility Criteria
Inclusion Criteria:
- Age 18-80 years old
- Clinical diagnosed hypertension with the use of antihypertensive drugs
- A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
- Willing to provide information about disease history and blood biochemical test data within 6 months.
- Sign the informed consent
Exclusion Criteria:
- Without antihypertensive drug use
- Hospitalized hypertension patients
- Non-compliant patient
Key Trial Info
Start Date :
July 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03547856
Start Date
July 18 2018
End Date
December 30 2026
Last Update
January 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, Shanghai Municipality, China, 200025